Four takeaways from the latest round of federal CBD warning letters

The young CBD industry is growing accustomed to federal health authorities warning companies not to make medical claims about the cannabinoid.

But a round of warning letters this week from the U.S. Federal Trade Commission (FTC) – the consumer-protection agency that safeguards against unfair and deceptive advertising – served as a reminder that as CBD goes mainstream, more federal agencies are giving the industry a critical look.

This week’s FTC warnings went to three unidentified CBD companies. Among other complaints, the FTC criticized the businesses for:

  • Posting on a website that CBD “works like magic.”
  • Advertising CBD as a “miracle pain remedy.”
  • Touting a CBD cream’s ability to relieve arthritis pain.
  • Using a partnership with Harvard University researchers to bolster claims that CBD has been “clinically proven to treat cancer, Alzheimer’s disease, multiple sclerosis, fibromyalgia, cigarette addiction and colitis.”

The

... read more at: https://hempindustrydaily.com/takeaways-from-the-latest-round-of-federal-cbd-warning-letters/

by

Leave a Reply